- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

A man was arrested for allegedly beheading his girlfriend when she asked him to marry her, police said on Sunday. "The case began after police found a headless body of a woman near Jagannathpur ...

Sami Sheen revealed that she hasn’t spoken to her dad Charlie Sheen in over 5 months as she opened up about their fractured relationship. On Tuesday’s episode of “Denise Richards & Her Wild ...

Olivia Klopchin/TikTok A woman born with a vascular malformation that makes one of her arms larger than the other is opening up about the condition on TikTok, saying it "doesn't stop her from ...

She started by aiming to do one pull-up, which took her a year of strength training to achieve. MacColl set herself an achievable goal and was consistent with her workouts. At 73, Ginny MacColl ...

Adam Nichols is Raw Story's Editor-in-Chief. He has more than 25 years of journalism experience, which includes working for the New York Daily News, the New York Post and DNAinfo, a startup site ...

"I think Andrew Garfield's face came up for me so many times. Multiple times," Glaser said, to which Paltrow responded, "That would have been a good one. He's gorgeous." "I'm sure he just didn't ...

Adidas To that end, her latest partnership with Adidas as the face of the new colorways for the Supernova Rise 2 shoe is right up her alley as someone who has a self-professed "love-hate ...

The teen looked all grown up in full glam with a half-up, half-down hairstyle. Maddie’s date complimented her colorful attire in a light gray suit, purple bow tie and matching boutonniere.

If we want to, we can, too. By Melissa Kirsch Daylight is adding up, about three minutes more each day as March progresses, give or take. Tomorrow, we bank a full hour at once: Change your clocks ...

AstraZeneca bought Belgian biotech company EsoBiotec in a deal valued at up to $1 billion, to expand its cell-therapy portfolio. The British pharma company said Monday that it will pay $425 ...